Cargando…
Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion
Recently, highly transmissible severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 with mutations within the spike proteins were identified in India. The spike protein of Kappa contains the four mutations E154K, L452R, E484Q, and P6...
Autores principales: | Ren, Wenlin, Ju, Xiaohui, Gong, Mingli, Lan, Jun, Yu, Yanying, Long, Quanxin, Kenney, Devin J., O’Connell, Aoife K., Zhang, Yu, Zhong, Jin, Zhong, Guocai, Douam, Florian, Wang, Xinquan, Huang, Ailong, Zhang, Rong, Ding, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040861/ https://www.ncbi.nlm.nih.gov/pubmed/35266815 http://dx.doi.org/10.1128/mbio.00099-22 |
Ejemplares similares
-
Genome Sequences of the Delta Variant (B.1.617.2) and the Kappa Variant (B.1.617.1) Detected in Morocco
por: Melloul, Marouane, et al.
Publicado: (2021) -
Genetic emergence of B.1.617.2 in COVID-19
por: Kirola, L.
Publicado: (2021) -
The neutralization of B.1.617.1 and B.1.1.529 sera from convalescent patients and BBIBP-CorV vaccines
por: Yang, Xinyi, et al.
Publicado: (2022) -
Variable neutralizing antibody responses to 10 SARS-CoV-2 variants in natural infection with wild- type (B.1) virus, Kappa (B.1.617.1), and Delta (B.1.617.2) variants and COVISHIELD vaccine immunization in India: utility of the MSD platform
por: Patil, Rajashree, et al.
Publicado: (2023) -
Analysis of the Delta Variant B.1.617.2 COVID-19
por: Shiehzadegan, Shayan, et al.
Publicado: (2021)